OXB
(LSE) OXB
OXB Financials at a Glance
Market Cap
$68.41B
Revenue (TTM)
$297.54M
Net Income (TTM)
$73.32M
EPS (TTM)
$-27.98
P/E Ratio
-20.23
Dividend
$0.00
Beta (Volatility)
-0.10 (Low)
Dividend
$0.00
Beta (Volatility)
-0.10 (Low)
Price
$572.00
Volume
162,585
Open
$575.00
Price
$572.00
Volume
162,585
Open
$575.00
Previous Close
$572.00
Daily Range
$555.06 - $582.98
52-Week Range
$270.00 - $951.69
Dividend
$0.00
Beta (Volatility)
-0.10 (Low)
Price
$572.00
Volume
162,585
Open
$575.00
Previous Close
$572.00
Daily Range
$555.06 - $582.98
52-Week Range
$270.00 - $951.69
OXB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout OXB
Industry
Biotechnology
Sector
Health CareEmployees
986
CEO
Frank Mathias, PhD
Website
www.oxfordbiomedica.co.ukHeadquarters
Oxford, OX4 6LT, GB
OXB Financials
Key Financial Metrics (TTM)
Gross Margin
39%
Operating Margin
-20%
Net Income Margin
-18%
Return on Equity
-41%
Return on Capital
-14%
Return on Assets
-9%
Earnings Yield
-4.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$68.41B
Shares Outstanding
120.87M
Volume
162.59K
Short Interest
0.00%
Avg. Volume
363.00K
Financials (TTM)
Gross Profit
$65.98M
Operating Income
$33.54M
EBITDA
$33.54M
Operating Cash Flow
$5.45M
Capital Expenditure
$4.76M
Free Cash Flow
$10.21M
Cash & ST Invst.
$96.88M
Total Debt
$106.64M
OXB Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$95.52M
+105.5%
Gross Profit
$34.32M
+93.0%
Gross Margin
35.93%
N/A
Market Cap
$68.41B
N/A
Market Cap/Employee
$80.48M
N/A
Employees
850
N/A
Net Income
$3.77M
+96.6%
EBITDA
$9.35M
+91.7%
Quarterly Fundamentals
Net Cash
$9.76M
-26.0%
Accounts Receivable
$65.18M
+388.5%
Inventory
$17.33M
+34.6%
Long Term Debt
$100.58M
-6.7%
Short Term Debt
$6.06M
-17.1%
Return on Assets
-9.25%
N/A
Return on Invested Capital
-13.89%
N/A
Free Cash Flow
$11.06M
+60.6%
Operating Cash Flow
$7.81M
+66.2%